Jianfen Zhou

Fudan University & State Key Laboratory Of Advanced Drug Formulations For Overcoming Delivery Barriers
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.

A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy.

Journal: Asian journal of pharmaceutical sciences
Published: September 23, 2025

Quantitative to qualitative transition: comparison of in vitro and in vivo behavior and glioma-targeted delivery of PEGylated lipid-based nanoparticles.

Quantitative to qualitative transition: comparison of in vitro and in vivo behavior and glioma-targeted delivery of PEGylated lipid-based nanoparticles.

Journal: Nanoscale
Published: July 14, 2025

Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3.

Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3.

Journal: Biomaterials
Published: February 11, 2025

Anti-CD33 antibody enhances liposomal co-delivery of cytarabine and daunorubicin for targeted combination chemotherapy.

Anti-CD33 antibody enhances liposomal co-delivery of cytarabine and daunorubicin for targeted combination chemotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 05, 2025

All-stage targeted nanodiscs for glioma treatment by inducing cuproptosis and apoptosis of cancer cells and cancer stem cells.

All-stage targeted nanodiscs for glioma treatment by inducing cuproptosis and apoptosis of cancer cells and cancer stem cells.

Journal: Asian journal of pharmaceutical sciences
Published: June 18, 2024

A novel peptide-drug conjugate for glioma-targeted drug delivery.

A novel peptide-drug conjugate for glioma-targeted drug delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 19, 2023

All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment.

All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 23, 2023

Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs.

Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 07, 2022

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.

Journal: Acta pharmaceutica Sinica. B
Published: February 21, 2022

In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy.

In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 28, 2022

Engineered platelets-based drug delivery platform for targeted thrombolysis.

Engineered platelets-based drug delivery platform for targeted thrombolysis.

Journal: Acta pharmaceutica Sinica. B
Published: October 15, 2021

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 14, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026